Cargando…
Molecular endpoints of Ca(2+)/calmodulin- and voltage-dependent inactivation of Ca(v)1.3 channels
Ca(2+)/calmodulin- and voltage-dependent inactivation (CDI and VDI) comprise vital prototypes of Ca(2+) channel modulation, rich with biological consequences. Although the events initiating CDI and VDI are known, their downstream mechanisms have eluded consensus. Competing proposals include hinged-l...
Autores principales: | , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2828906/ https://www.ncbi.nlm.nih.gov/pubmed/20142517 http://dx.doi.org/10.1085/jgp.200910308 |
_version_ | 1782178039908532224 |
---|---|
author | Tadross, Michael R. Johny, Manu Ben Yue, David T. |
author_facet | Tadross, Michael R. Johny, Manu Ben Yue, David T. |
author_sort | Tadross, Michael R. |
collection | PubMed |
description | Ca(2+)/calmodulin- and voltage-dependent inactivation (CDI and VDI) comprise vital prototypes of Ca(2+) channel modulation, rich with biological consequences. Although the events initiating CDI and VDI are known, their downstream mechanisms have eluded consensus. Competing proposals include hinged-lid occlusion of channels, selectivity filter collapse, and allosteric inhibition of the activation gate. Here, novel theory predicts that perturbations of channel activation should alter inactivation in distinctive ways, depending on which hypothesis holds true. Thus, we systematically mutate the activation gate, formed by all S6 segments within Ca(V)1.3. These channels feature robust baseline CDI, and the resulting mutant library exhibits significant diversity of activation, CDI, and VDI. For CDI, a clear and previously unreported pattern emerges: activation-enhancing mutations proportionately weaken inactivation. This outcome substantiates an allosteric CDI mechanism. For VDI, the data implicate a “hinged lid–shield” mechanism, similar to a hinged-lid process, with a previously unrecognized feature. Namely, we detect a “shield” in Ca(V)1.3 channels that is specialized to repel lid closure. These findings reveal long-sought downstream mechanisms of inactivation and may furnish a framework for the understanding of Ca(2+) channelopathies involving S6 mutations. |
format | Text |
id | pubmed-2828906 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | The Rockefeller University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-28289062010-09-01 Molecular endpoints of Ca(2+)/calmodulin- and voltage-dependent inactivation of Ca(v)1.3 channels Tadross, Michael R. Johny, Manu Ben Yue, David T. J Gen Physiol Article Ca(2+)/calmodulin- and voltage-dependent inactivation (CDI and VDI) comprise vital prototypes of Ca(2+) channel modulation, rich with biological consequences. Although the events initiating CDI and VDI are known, their downstream mechanisms have eluded consensus. Competing proposals include hinged-lid occlusion of channels, selectivity filter collapse, and allosteric inhibition of the activation gate. Here, novel theory predicts that perturbations of channel activation should alter inactivation in distinctive ways, depending on which hypothesis holds true. Thus, we systematically mutate the activation gate, formed by all S6 segments within Ca(V)1.3. These channels feature robust baseline CDI, and the resulting mutant library exhibits significant diversity of activation, CDI, and VDI. For CDI, a clear and previously unreported pattern emerges: activation-enhancing mutations proportionately weaken inactivation. This outcome substantiates an allosteric CDI mechanism. For VDI, the data implicate a “hinged lid–shield” mechanism, similar to a hinged-lid process, with a previously unrecognized feature. Namely, we detect a “shield” in Ca(V)1.3 channels that is specialized to repel lid closure. These findings reveal long-sought downstream mechanisms of inactivation and may furnish a framework for the understanding of Ca(2+) channelopathies involving S6 mutations. The Rockefeller University Press 2010-03 /pmc/articles/PMC2828906/ /pubmed/20142517 http://dx.doi.org/10.1085/jgp.200910308 Text en © 2010 Tadross et al. https://creativecommons.org/licenses/by-nc-sa/3.0/This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/ (https://creativecommons.org/licenses/by-nc-sa/3.0/) ). |
spellingShingle | Article Tadross, Michael R. Johny, Manu Ben Yue, David T. Molecular endpoints of Ca(2+)/calmodulin- and voltage-dependent inactivation of Ca(v)1.3 channels |
title | Molecular endpoints of Ca(2+)/calmodulin- and voltage-dependent inactivation of Ca(v)1.3 channels |
title_full | Molecular endpoints of Ca(2+)/calmodulin- and voltage-dependent inactivation of Ca(v)1.3 channels |
title_fullStr | Molecular endpoints of Ca(2+)/calmodulin- and voltage-dependent inactivation of Ca(v)1.3 channels |
title_full_unstemmed | Molecular endpoints of Ca(2+)/calmodulin- and voltage-dependent inactivation of Ca(v)1.3 channels |
title_short | Molecular endpoints of Ca(2+)/calmodulin- and voltage-dependent inactivation of Ca(v)1.3 channels |
title_sort | molecular endpoints of ca(2+)/calmodulin- and voltage-dependent inactivation of ca(v)1.3 channels |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2828906/ https://www.ncbi.nlm.nih.gov/pubmed/20142517 http://dx.doi.org/10.1085/jgp.200910308 |
work_keys_str_mv | AT tadrossmichaelr molecularendpointsofca2calmodulinandvoltagedependentinactivationofcav13channels AT johnymanuben molecularendpointsofca2calmodulinandvoltagedependentinactivationofcav13channels AT yuedavidt molecularendpointsofca2calmodulinandvoltagedependentinactivationofcav13channels |